Mangalam Drugs & Organics Limited

NSE MANGALAM.NS

Mangalam Drugs & Organics Limited Price to Sales Ratio (P/S) on February 07, 2025: 0.46

Mangalam Drugs & Organics Limited Price to Sales Ratio (P/S) is 0.46 on February 07, 2025, a -6.72% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Mangalam Drugs & Organics Limited 52-week high Price to Sales Ratio (P/S) is 0.60 on August 26, 2024, which is 29.39% above the current Price to Sales Ratio (P/S).
Mangalam Drugs & Organics Limited 52-week low Price to Sales Ratio (P/S) is 0.39 on March 28, 2024, which is -16.20% below the current Price to Sales Ratio (P/S).
Mangalam Drugs & Organics Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 0.48.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: MANGALAM.NS

Mangalam Drugs & Organics Limited

CEO	Mr. Govardhan Murlidhar Dhoot
IPO Date	May 23, 2005
Location	India
Headquarters	Rupam Building
Employees	432
Sector	Healthcare
Industries Pharmaceuticals Chemicals & Advanced Materials Cleaning Supplies Drugstores & Retail Pharmacies Personal Care Petrochemicals

Description

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.

Key trends

Past 5 years